137 related articles for article (PubMed ID: 36995276)
1. Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature.
Vuillamy C; Arnault JP; Fumery M; Mortier L; Monestier S; Mansard S; Bens G; Duval-Modeste AB; Funck-Brentano E; Jeudy G; Machet L; Chaby G; Dadban A; Lok C;
Melanoma Res; 2023 Jun; 33(3):192-198. PubMed ID: 36995276
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: Clostridium difficile and inflammatory bowel disease.
Goodhand JR; Alazawi W; Rampton DS
Aliment Pharmacol Ther; 2011 Feb; 33(4):428-41. PubMed ID: 21198703
[TBL] [Abstract][Full Text] [Related]
3. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
4. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
9. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study.
Drozdinsky G; Atamna A; Banai H; Ben-Zvi H; Bishara J; Eliakim-Raz N
Medicine (Baltimore); 2023 Feb; 102(6):e32812. PubMed ID: 36820599
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
[TBL] [Abstract][Full Text] [Related]
14. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease.
Law CC; Tariq R; Khanna S; Murthy S; McCurdy JD
Aliment Pharmacol Ther; 2017 Apr; 45(8):1011-1020. PubMed ID: 28206678
[TBL] [Abstract][Full Text] [Related]
16. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.
Chen XL; Deng J; Chen X; Wan SS; Wang Y; Cao Q
J Dig Dis; 2019 Sep; 20(9):460-466. PubMed ID: 31278840
[TBL] [Abstract][Full Text] [Related]
17. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
Gawronska A; Banasiuk M; Lachowicz D; Pituch H; Albrecht P; Banaszkiewicz A
Inflamm Bowel Dis; 2017 Dec; 23(12):2209-2214. PubMed ID: 29084080
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and clinical characteristics of Clostridioides difficile infection in patients with inflammatory bowel disease from a teaching hospital.
Li YM; Liao JZ; Jian ZJ; Li HL; Chen X; Liu QX; Liu PL; Wang ZQ; Liu X; Yan Q; Liu WE
J Clin Lab Anal; 2022 Dec; 36(12):e24773. PubMed ID: 36397282
[TBL] [Abstract][Full Text] [Related]
20. The Risk of Diarrhea and Colitis in Patients With Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis.
Tandon P; Bourassa-Blanchette S; Bishay K; Parlow S; Laurie SA; McCurdy JD
J Immunother; 2018 Apr; 41(3):101-108. PubMed ID: 29401166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
